Modulatory Effect of Concomitant Administration of Insulin and Vanadium on Inflammatory Biomarkers in Type 2 Diabetic Rats: Role of Adiponectin

10.4077/CJP.2018.BAG523

Ismaeel Bin-Jaliah；Hussein F. Sakr；Mohamed D. Morsy；Mohamed Dallak；Mohamed A. Haidara

adiponectin ； cytokines ； diabetes ； insulin ； vanadium

The Chinese Journal of Physiology

61卷1期（2018 / 02 / 28）

42 - 49

英文

The aim of this study is to investigate the effect of vanadium and/or insulin on the proinflammatory biomarkers in type 2 diabetes mellitus (T2DM) rat model. Sixty male Sprague Dawley rats were divided into six groups (n = 10). Control group, control vanadium group, T2DM group, insulin-treated diabetic group, vanadium-treated diabetic group, and concomitant insulin and vanadium-treated diabetic group. At the end of the experiment, serum glucose, insulin, lipid profile, tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), high sensitivity C reactive protein (hs- CRP), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and adiponectin were measured. Administration of insulin and/or vanadium significantly decreased in the plasma levels of glucose, lipid profile, TNF-α, IL-6, hs-CRP, ICAM-1, and VCAM-1 with significant increase in adiponectin in comparison to the diabetic group. Concomitant administration of insulin and vanadium significantly improved the above measured parameters compared to either insulin or vanadium treatment. Based on our results we can conclude that administration of both vanadium and insulin reduced the low-grade systemic inflammation in T2DM, through reduction of both proinflammatory cytokines and adhesion molecules and increase adiponectin.

1. Abbas, A.M.,Sakr, H.F.(2016).Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothy-roidism.Can. J. Physiol. Pharmacol.,94,426-432.
2. Adamczak, M.,Wiecek, A.(2013).The adipose tissue as an endo-crine organ.Semin. Nephrol.,33,2-13.
3. Ajuwon, K.M.,Spurlock, M.E.(2005).Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes.Am. J. Physiol. Regul. Integr. Comp. Physiol.,288,16-21.
4. Bin-Jaliah, I.,Haidara, M.A.,Sakr, H.F.(2016).Ameliorative effects of concomitant vanadium treatment with insulin on systemic inflammation in a rat model of type 2 diabetes mellitus.Proc. Int. Conf. Physiol. Sci.
5. Cybulsky, M.I.,Iiyama, K.,Li, H.,Zhu, S.,Chen, M.(2001).A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.J. Clin. Invest.,107,1255-1262.
6. DeFronzo, R.A.,Tripathy, D.(2009).Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.Diabetes Care,32,157-163.
7. Di Raimondo, D.,Tuttolomondo, A.,Butta, C.,Casuccio, A.,Giarrusso, L.(2013).Metabolic and anti-inflammatory effects of a home-based programme of aerobic physical exercise.Int. J. Clin. Pract.,67,1247-1253.
8. Donath, M.Y.,Shoelson, S.E.(2011).Type 2 diabetes as an inflammatory disease.Nat. Rev. Immunol.,11,98-107.
9. Duncan, B.B.,Schmidt, M.I.,Pankow, J.S.,Ballantyne, C.M.,Couper, D.(2003).Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.Diabetes,52,1799-1805.
10. Ge, H.,Wen, Y.,Yang, G.,Betz, A.L.(2000).Increased expression of intercellular adhesion molecule-1 in mouse focal cerebral ischemia model.Chinese Med. J.,113,75-79.
11. Gruzewska, K.,Michno, A.,Pawelczyk, T.,Bielarczyk, H.(2014).Essentiality and toxicity of vanadium supplements in health and pathology.J. Physiol. Pharmacol.,65,603-611.
12. Gumuslu, E.,Cine, N.,Gökbayrak, M.E.,Mutlu, O.,Celikyurt, I.K.,Ulak, G.(2016).Exenatide alters gene expression of neural cell adhesion molecule (NCAM), intercellular cell adhesion molecule (ICAM), and vascular cell adhesion molecule (VCAM) in the hippocampus of type 2 diabetic model mice.Med. Sci. Monit.,22,2664-2669.
13. Haidara, M.A.,Khloussy, H.,Ammar, H.,Aal Kassem, L.A.(2004).Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes.Med. Sci. Monit.,10,BR41-BR46.
14. Haidara, M.A.,Yassin, H.Z.,Zakula, Z.,Mikhailidis, D.P.,Isenovic, E.R.(2010).Diabetes and antioxidants: myth or reality?.Curr. Vasc. Pharmacol.,8,661-672.
15. Hirosumi, J.,Tuncman, G.,Chang, L.,Gorgun, C.Z.,Uysal, K.T.(2002).A central role for JNK in obesity and insulin resistance.Nature,420,333-336.
16. Hotamisligil, G.S.(2006).Inflammation and metabolic disorders.Nature,444,860-867.
17. Hotamisligil, G.S.,Erbay, E.(2008).Nutrient sensing and inflammation in metabolic diseases.Nat. Rev. Immunol.,8,923-934.
18. Hussein, A.,Omar, N.M.,Sakr, H.,Elsamanoudy, A.Z.,Shaheen, D.(2011).Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus.Can. J. Physiol. Pharmacol.,89,216-226.
19. Kedziora-Kornatowska, K.Z.,Luciak, M.,Blaszczyk, J.,Pawlak, W.(1998).Effect of aminoguanidine on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes.Clin. Chem. Lab. Med.,36,771-775.
20. Kern, P.A.,Di Gregorio, G.B.,Lu, T.,Rassouli, N.,Ranganathan, G.(2003).Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression.Diabetes,52,1779-1785.
21. Khalfaoui, T.,Lizard, G.,Ouertani-Meddeb, A.(2008).Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.J. Mol. Histol.,39,243-149.
22. Kim, A.Y.,Park, Y.J.,Pan, X.,Shin, K.C.,Kwak, S.H.(2015).Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance.Nat. Commun.,6,7585.
23. Kolb, H.,Mandrup-Poulsen, T.(2005).An immune origin of type 2 diabetes?.Diabetologia,48,1038-1050.
24. Libby, P.,Okamoto, Y.,Rocha, V.Z.,Folco, E.(2010).Inflammation in atherosclerosis: transition from theory to practice.Circ. J.,74,213-220.
25. Liu, Y.,Xu, J.,Guo, Y.,Xue, Y.,Wang, J.,Xue, C.(2015).Ameliorative effect of vanadyl(IV)-ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice.J. Trace Elem. Med. Biol.,32,155-161.
26. Liu, Y.,Zhou, Q.,Zhao, Y.,Wang, Y.,Wang, J.(2016).Enrichment, distribution of vanadium-containing protein in vanadium-enriched sea cucumber apostichopus japonicus and the ameliorative effect on insulin resistance.Biol. Trace Elem. Res.,171,167-175.
27. Maeda, N.,Takahashi, M.,Funahashi, T.,Kihara, S.,Nishizawa, H.(2001).PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.Diabetes,50,2094-2099.
28. Marzban, L.,McNeil, J.H.(2003).Insulin-like actions of vanadium: potential as a therapeutic agent.J. Trace Ele. Exp. Med.,16,253-267.
29. Morsy, M.D.,Abdel-Razek, H.A.,Osman, O.M.(2011).Effect of vanadium on renal Na+, K+-ATPase activity in diabetic rats: a possible role of leptin.J. Physiol. Biochem.,67,61-69.
30. Pradhan, A.D.,Manson, J.E.,Rifai, N.,Buring, J.E.,Ridker, P.M.(2001).C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.JAMA,286,327-334.
31. Ramanadham, S.,Cros, G.H.,Mongold, J.J.,Serrano, J.J.,McNeill, J.H.(1990).Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin.Can. J. Physiol. Pharmacol.,68,486-491.
32. Sakr, H.F.(2013).Modulation of metabolic and cardiac dysfunctions by swimming in overweight rats on a high cholesterol and fructose diet: possible role of adiponectin.J. Physiol. Pharmacol.,64,231-240.
33. Sakr, H.F.,Al-Hashem, F.H.,El-Naby, W.M.,Alkhateeb, M.A.,Zaki, M.S.(2014).Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome.Can. J. Physiol. Pharmacol.,92,162-170.
34. Sakurai, H.(2002).A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.Chem. Rec.,2,237-248.
35. Smith, D.T.,Carr, L.J.,Dorozynski, C.,Gomashe, C.(1985).Internet-delivered lifestyle physical activity intervention: limited inflammation and antioxidant capacity efficacy in overweight adults.J. Appl. Physiol.,106,49-56.
36. Srivastava, A.K.(2000).Anti-diabetic and toxic effects of vanadium compounds.Mol. Cell. Biochem.,206,177-182.
37. Srivastava, A.K.,Mehdi, M.Z.(2005).Insulino-mimetic and anti-diabetic effects of vanadium compounds.Diabet. Med.,22,2-13.
38. Thompson, K.H.,Orvig, C.(2006).Vanadium in diabetes: 100 years from phase 0 to phase I.J. Inorg Biochem.,100,1925-1935.
39. Tilg, H.(2010).The role of cytokines in non-alcoholic fatty liver disease.Dig. Dis.,28,179-185.
40. Trayhurn, P.,Beattie, J.H.(2001).Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.Proc. Nutr. Soc.,60,329-339.
41. Unlucerci, Y.,Bekpinar, S.,Gurdol, F.,Seferoglu, G.(2002).A study on the relationship between homocysteine and diabetic nephropathy in rats.Pharmacol. Res.,45,249-252.
42. Uysal, K.T.,Wiesbrock, S.M.,Marino, M.W.,Hotamisligil, G.S.(1997).Protection from obesity-induced insulin resistance in mice lacking TNF-α function.Nature,389,610-614.
43. Venkatesh, B.,Hickman, I.,Nisbet, J.,Cohen, J.,Prins, J.(2009).Changes in serum adiponectin concentrations in critical illness: a preliminary investigation.Crit. Care,13,20.
44. Wellen, K.E.,Hotamisligil, G.S.(2005).Inflammation, stress, and diabetes.J. Clin. Invest.,115,1111-1119.
45. Yudkin, J.S.,Stehouwer, C.D.,Emeis, J.J.,Coppack, S.W.(1999).Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?.Arterioscler. Thromb. Vasc. Biol.,19,972-978.
46. Yuen, V.G.,Orvig, C.,McNeill, J.H.(1995).Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato) oxovanadium(IV) following acute and chronic administration.Can. J. Physiol. Pharmacol.,73,55-64.
47. Zhang, K.,Shen, X.,Wu, J.,Sakaki, K.,Saunders, T.(2006).Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response.Cell,124,587-599.